RT @MIRimaging: Timely therapy recommendations are crucial for multiple myeloma patients. MIR and other @WUSTLmed researchers assessed a pr…
RT @MIRimaging: Timely therapy recommendations are crucial for multiple myeloma patients. MIR and other @WUSTLmed researchers assessed a pr…
Timely therapy recommendations are crucial for multiple myeloma patients. MIR and other @WUSTLmed researchers assessed a promising tracer for an in vivo therapeutic response in disseminated #multiplemyeloma models following bortezomib therapy. https://t.co
PC | In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [18F]FDG and [64Cu]Cu-LLP2A PET https://t.co/B6yKF61f8i
RT @PaperbirdsM: New article: In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models o…
New article: In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [(18)F]FDG and [(64)Cu]Cu-LLP2A PET https://t.co/4Y5Lo6wXfV #MMSM #MultipleMyeloma #hematology https://t.co/oD